Olive M, Williams S C, Dezan C, Johnson P F, Vinson C
Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 1996 Jan 26;271(4):2040-7. doi: 10.1074/jbc.271.4.2040.
We have developed a bZIP protein, GBF-F, with both dominant-negative (DN) and gain-of-function properties. GBF-F is a chimera consisting of two components: the DNA binding (basic) region from the plant bZIP protein GBF-1 (GBF) and a leucine zipper (F) designed to preferentially heterodimerize with the C/EBP alpha leucine zipper. Biochemical studies show that GBF-F preferentially forms heterodimers with C/EBP alpha and thus binds a chimeric DNA sequence composed of the half-sites recognized by the C/EBP and GBF basic regions. Transient transfections in HepG2 hepatoma cells show that both components of GBF-F are necessary for inhibition of C/EBP alpha transactivation. When the C/EBP alpha leucine zipper is replaced with that of either GCN4 or VBP, the resulting protein can transactivate a C/EBP cis-element but is not inhibited by GBF-F, indicating that the specificity of dominant-negative action is determined by the leucine zipper. All known members of the C/EBP family contain similar leucine zipper regions and are inhibited by GBF-F. GBF-F also exhibits gain-of-function properties, since, with the essential cooperation of a C/EBP family member, it can transactivate a promoter containing the chimeric C/EBP/GBF site. This protein therefore has potential utility both as a dominant-negative inhibitor of C/EBP function and as an activator protein with novel DNA sequence specificity.
我们已经开发出一种具有显性负性(DN)和功能获得特性的bZIP蛋白GBF-F。GBF-F是一种嵌合体,由两个部分组成:来自植物bZIP蛋白GBF-1(GBF)的DNA结合(碱性)区域和一个设计用于优先与C/EBPα亮氨酸拉链异源二聚化的亮氨酸拉链(F)。生化研究表明,GBF-F优先与C/EBPα形成异源二聚体,从而结合由C/EBP和GBF碱性区域识别的半位点组成的嵌合DNA序列。在HepG2肝癌细胞中的瞬时转染表明,GBF-F的两个组成部分对于抑制C/EBPα反式激活都是必需的。当C/EBPα亮氨酸拉链被GCN4或VBP的亮氨酸拉链取代时,所得蛋白可以反式激活C/EBP顺式元件,但不受GBF-F抑制,这表明显性负性作用的特异性由亮氨酸拉链决定。C/EBP家族的所有已知成员都含有相似的亮氨酸拉链区域,并受到GBF-F的抑制。GBF-F还表现出功能获得特性,因为在C/EBP家族成员的必要协同作用下,它可以反式激活含有嵌合C/EBP/GBF位点的启动子。因此,这种蛋白作为C/EBP功能的显性负性抑制剂和具有新DNA序列特异性的激活蛋白都具有潜在用途。